| A | B |
|---|
| Swallowing | results in dietary changes in patients with progressing Parkinson's disease |
| Tremors | movement involving the hands, lip, jaw, or tongue; worse during emotional distress |
| Dyskinesia | impariment of the ability to control voluntary movements |
| Constipation | common side effect found with all Parkinson's medications |
| Safety | one of the biggest concerns for patients with Parkinson's disease |
| Selegiline | MAO-B inhibitor associated with management of Parkinson's disease |
| Requip | many uses but also used in early stages of Parkinson's management |
| Anticholinergic | agents that provide symptomatic relief from excessive acetylcholine |
| Apomorphine | mainline dopamine agonist used for managment of Parkinson's disease |
| Benadryl | drug with many uses but is an anticholinergic agent |
| Dopamine | inhibitory neurotransmitter |
| Sinemet | mainline combination drug for management of Parkinson's disease |
| Acetylcholine | excitatory neurotransmitter |
